Barrow Robert sold DFTX
June 25, 2026 · Form 4 insider transaction
Barrow Robert sold 29,208 shares of Definium Therapeutics, Inc. at $45.03 per share, a transaction worth $1.32M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
29,208
Price
$45.03
Total value
$1.32M
InsiderBarrow Robert
RoleOfficer, Director
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateJune 25, 2026
Filing dateJune 26, 2026
Shares owned after1,098,246
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections under a Rule 10b5-1 plan adopted on June 15, 2022.